Halozyme Therapeutics (HALO) Stock Highlights

62.31 | +0.61%

2024-09-19 00:18:11

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme utilizes a strategy that focuses on developing its own proprietary products in therapeutic areas with significant unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The companys operations are based in the United States, with minimal long-lived assets located internationally.

Statistics

Range Today

61.3 63.5

Volume Today 1.18M

Range 1 Year

32.83 65.53

Volume 1 Year 291.49M

Range 3 Year

29.85 65.53

Volume 3 Year 868.29M

Range 10 Year

6.96 65.53

Volume 10 Year 3.16B

Highlights

Market Capitalization 7.89B (mid)

Floating Shares 125.34M

Current Price 62.31

Price To Earnings 23.65

Price To Revenue 9.93

Price To Book 27.24

Earnings Per Share 2.58

Payout Ratio 0%

Performance

Latest +0.61%

1 Month +4.86%

3 Months +25.27%

6 Months +52.24%

1 Year +58.87%

3 Years +51.57%

5 Years +278.78%

10 Years +522.48%

Benchmarks

Market Capitalization

33 / 368

Gross Profits

17 / 278

Total Revenue

20 / 300

Total Rank

140 / 368

Free Cashflow

7 / 352

Performance 5 years

28 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.